Gallant Shark Tank Update

Gallant Shark Tank Update – What Happened To Gallant? 

Was Gallant on Shark Tank? Yes, it was. In the eighth episode of Season 11 of Shark Tank, Aaron Hirschhorn appeared to present his innovative venture called Gallant. Hirschhorn was seeking a $500,000 investment in exchange for a 2% stake in his company, which specializes in stem cell therapy for dogs.

Gallant collaborates closely with veterinarians to provide a unique service: stem cell banking for pets. This service enables pet owners to store their pets’ stem cells for future use in case their beloved companions face common health issues. 

The business model adopted by Gallant is remarkably innovative. Recognizing that many household dogs undergo spaying or neutering procedures, Gallant offers a solution to utilize and store the typically discarded reproductive organs. Let us find out about the Gallant shark tank update.

Gallant Shark Tank Profile

Here is Gallant at a glance.

Company NameGallant
FounderAaron Hirschhorn
ServiceStem cell banking for pets
AnimalsDogs, cats, and horses
Shark Tank EpisodeSeason11, Episode 8
Air Date17th November 2019
Asked for$500,000 for 2% equity
Final Deal$500,000 for 5% equity
SharkAnne Wojcicki And Lori Greiner
Business StatusIn business
Cost$595/year, $95/month, and a $205 one-time setup fee
HeadquartersPhiladelphia, USA
Net worth$25 million
Deal after shark tankNot closed
Competitive PerformanceRanked 1st among its competitors
Watch OnPrime Video, Hulu, FubuTV

What Is Gallant?

Gallant, founded by Aaron Hirschhorn, is a groundbreaking company that has brought about a transformative revolution in stem cell therapy. Gallant’s mission is to extend regenerative care, utilizing stem cell treatments, not only to dogs but also to cats and horses.

Through close collaboration with veterinarians, Gallant empowers pet owners to store their beloved animals’ stem cells for future use. This proactive approach ensures that pet owners have a potential solution readily available if their cherished companions face health issues that can benefit from regenerative cell therapy.

What Is Gallant

Gallant identified an opportunity to harness and preserve the valuable regenerative cells in the otherwise discarded reproductive organs.

Gallant’s commitment to advancing the field of regenerative medicine for animals distinguishes the company as an exceptional and pioneering force within the industry. By offering pet owners an innovative solution for their pets’ health needs, Gallant continues to pave the way for improved well-being and animal care.

What Happened in Gallant Shark Tank Episode? 

During the Gallant shark tank episode aired on 17th November 2019, Aaron walks in with a basket full of puppies. His approach catches the sharks’ attention as he begins his pitch. Aaron asks for $500,000 for 2% equity. 

He explains what Gallant is all about and how to stem therapy works. Aaron carefully says that when a dog’s organs are collected, they are isolated and stored within an advanced FDA-approved laboratory. The organs are then meticulously preserved using liquid nitrogen. 

“The stored stem cells hold promising potential as a remedy for various medical conditions dogs may encounter,” Aaron says. Despite the promising research and evidence, the sharks are still not convinced why they should invest in Gallant.

Anne Wojcicki points out her concerts when Aaron says that Gallant is currently operating at a loss, primarily due to their substantial payment to vets. Due to Anne’s concerns, Daymond John decides to withdraw. 

On the other hand, Kevin O’Leary extends two offers: $500,000 for a 2% equity and 2% stock options or $500,000 for a 1% equity stake and a 10% royalty on each kit sold indefinitely.

Mark Cuban opts out, saying the company should sort its financial issues first. After some deliberation, Anne and Lori Greiner join forces, proposing an investment of $500,000 for an 8% equity. 

Aaron brings up an alternative offer for 4% equity. This leads to further negotiation resulting in a final agreement of 5%. With no other enticing offers, Aaron accepts their offer.

Unfortunately, the deal did not close afterward, but Gallant is still in business. Here is the Gallant shark tank update

What Happened To Gallant After Shark Tank?

After Shark Tank, Aaron did take Anne’s advice and raised his initial lifetime price of $595 to $890. Alternatively, monthly plans are available at $95, with a one-time setup fee of $205. This pricing structure has proven highly lucrative, contributing to Gallant’s profitability.

Gallant was expected to generate $2.5 million in annual revenue by 2022, a testament to its successful operations. These financial indicators demonstrate Gallant’s current success and solid profit margins. 

What Happened To Gallant After Shark Tank

Gallant today maintains its reputation as a reputable and prosperous company by maintaining its business operations and financial performance. The company’s ability to provide high-quality services while remaining financially sound has contributed to its ongoing growth and success.

Regrettably, despite Gallant’s ongoing success, Aaron, the company’s visionary, was tragically unable to witness or enjoy its accomplishments. According to The Miami Herald, Aaron died in a boating accident in Miami on March 28, 2021. 

The news of Aaron’s departure came as a shock to the company and the community that his entrepreneurial spirit had inspired. Although Aaron is no longer with Gallant, his vision and contributions continue to resonate within the company and serve as a testament to his enduring legacy. The new CEO for Gallant is Linda Black.

Gallant Net Worth

According to available information, Gallant’s net worth was reported to be an impressive $25 million before shark tank.  This valuation highlights the substantial value and market position that the company has attained.

With its innovative approach to stem cell research and unique business model, Gallant has captured a substantial market share. It has also established itself as a prominent player in the industry. 

The company’s dedication to regenerative dog care and collaboration with veterinarians have contributed to its remarkable growth and financial success.

Gallant’s $25 million net worth indicates its financial strength and potential for continued growth and expansion. This valuation reflects the accumulated assets, revenues, and overall market perception of the company’s value. It is a testament to Gallant’s achievements, the quality of its services, and the recognition it has garnered within the industry.

Gallant sales data

Since being a privately held company, Gallant doesn’t disclose their sales data to the public. As of this, we couldn’t find their yearly sales data. 

Is Gallant Profitable Now?

Gallant has demonstrated impressive profitability in recent years. 2020 the company reportedly generated approximately $2.5 million in annual revenue, indicating a solid financial performance. Additionally, Gallant was valued at $25 million in 2022, further underscoring its profitability and market worth.

While specific details about the company’s current financial status are not provided, the data from 2022 suggests that Gallant has established a robust foundation for profitability. With its innovative business model and ongoing success, it is reasonable to infer that Gallant has likely maintained or even improved upon its profitability in subsequent years.

Is Gallant Profitable Now

The company’s ability to offer various membership options, including lifetime memberships and monthly plans, indicates a sustainable revenue stream. Moreover, the solid profit margins mentioned earlier suggest that Gallant has effectively managed its costs and maximized its financial performance.

If you’re interested in more Shark Tank updates, be sure to check out our articles on Sparketh and Larq. Our Sparketh Shark Tank update explores the online platform that provides creative arts education for kids, similar to the journey of Gallant. Additionally, our Larq Shark Tank update highlights the innovative self-cleaning water bottle that attracted the attention of the Sharks. Discover the remarkable stories of these entrepreneurs and their successful Shark Tank ventures.


Aaron Hirschhorn’s compelling pitch for Gallant successfully captivated two of the sharks. Despite initial skepticism, Aaron’s personal experience with the effectiveness of stem cell treatments demonstrated the potential of Gallant’s business model.

Although the agreed deal between him, Anne Wojcicki, and Lori Greiner for $500,000 for a 5% stake was unsuccessful, Gallant continues to grow and thrive. By utilizing the regenerative potential of stem cells, Gallant aims to enhance the quality of life for pets. 

It also provides pet owners with effective and innovative solutions. Gallant’s commitment to cutting-edge research and development has positioned them at the forefront of the stem cell industry. 

Gallant’s success is a lasting tribute to Aaron Hirschhorn’s innovative spirit, impacting animal healthcare and stem cell therapy. Gallant’s legacy lives on as it continues to be at the forefront of pioneering advancements and compassionate care for our four-legged friends. 

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *